Date posted: April 7, 2020, 6:00 am
In this episode, we chat with Eris Tollkuci, PharmD, BCOP regarding what every non-onc healthcare provider should know about immune checkpoint inhibitors (specifically PD-1/PD-L1 inhibitors) in patients with cancer.
Date posted: March 17, 2020, 6:00 am
In this episode, we summarize some of the most significant changes in the newest version of American Diabetes Association - 2020 Standards of Medical Care in Diabetes guidelines.
Date posted: February 25, 2020, 6:00 am
In this episode, we review the pros, cons, and literature regarding the use of DOACs versus warfarin in obese patients with venous thromboembolism.
Date posted: February 4, 2020, 6:00 am
In this episode, we provide an overview of lifestyle medicine, its six pillars, and how it plays a role in improving health outcomes.
Date posted: January 14, 2020, 6:00 am
In this episode, we discuss clinical pearls and management related to chronic and acute hyperkalemia.
Date posted: December 24, 2019, 6:00 am
In this episode, we discuss the important updates in the 2019 IDSA Community Acquired Pneumonia (CAP) guidelines with Dr. Christie Bertram, PharmD, an Infectious Diseases Clinical Pharmacist and Assistant Professor at 无码群交’s College of Pharmacy.
Date posted: December 3, 2019, 6:00 am
In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent’s clinical pearls, comparative effectiveness, and unique precautions.
Date posted: November 12, 2019, 6:00 am
In this episode, we will discuss what is the latest and greatest from the GINA (Global INitiative for Asthma) 2019 guidelines, including new recommendations regarding rescue inhalers, tiotropium, and azithromycin for asthma.
Date posted: October 22, 2019, 6:00 am
In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a drug for diabetes) among patients who had heart failure with reduced ejection fraction (HFrEF) many of which did NOT have a history of diabetes.
Date posted: October 1, 2019, 6:00 am
In this episode, we provide an overview of chronic idiopathic constipation and discuss available treatment options with a particular focus on lubiprostone, linaclotide, plecanatide, and prucalopride.